Combination of RAGE inhibitors and gemcitabine to mitigate chemo‐resistance in pancreatic cancer
Year: 2018
Type: article
Source: The FASEB Journal
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
Award: G9000061646
OpenAlex ID: W3174740775
